Notice NOT-OD-18-140 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-673 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support students at institutions without formal NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g., DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individuals potential to develop into a productive, independent physician/clinician-scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Funding Opportunity PA-18-672 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Notice NOT-MH-18-023 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-133 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-598 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Bioinformatics Project Manager London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with the 100,000 London, England

Celgene: Other Locations:US- WA- Seattle; US- MA- Cambridge; US- CA- San Diego; US- CA- San Francisco- Emeryville; US- NJ- Summit WestDescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, bette Cambridge, Massachusetts (US)

Funding Opportunity RFA-OD-18-004 from the NIH Guide for Grants and Contracts. The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.

Interested applicants should apply online and attach their curriculum vitae, statement of research interests, and contact information of three references....
From Medical College of Wisconsin - Mon, 19 Feb 2018 21:08:26 GMT - View all Milwaukee, WI jobs

Negotiable: Paramount Recruitment: Senior Cancer Analyst Paramount are working in partnership with Genomics England on the continued development of their world class bioinformatics team based in London. London, England

Negotiable: Paramount Recruitment: Contract Bioinformatician - Berkshire - ASAP start 12-Month Contract - Translational Bioinformatics - NGS Analysis - Genomics A great opportunity is available for a Bioinformatician to join a global Bio-Pharma based in the UK. Berkshire, England

Previous experience working with Next Generation Sequencing Platforms and bioinformatics. In a biological science....
From Adaptive Biotechnologies - Sat, 17 Feb 2018 02:05:07 GMT - View all Seattle, WA jobs

Funding Opportunity PA-18-671 from the NIH Guide for Grants and Contracts. The purpose of the Kirschstein-NRSA predoctoral fellowship (F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the applicants dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Negotiable: Paramount Recruitment: Bioinformatics Cancer Analyst Paramount are currently working with one of the leading figures in oncology drug discovery and development that is seeking to expand their talented Bioinformatics team. This is a permanent Bioinformatics Analyst position to Cambridge, England

Negotiable: Paramount Recruitment: Head of Bioinformatics - Hertfordshire Brand new opportunity for a Head of Bioinformatics at one of the country's most exciting biotechs, heading up pioneering research into the next generation of personalised medicines for cancer. Hertfordshire, England

Negotiable: Paramount Recruitment: Bioinformatics Analyst A fantastic opportunity has become available for a talented Bioinformatics Analyst to join some of the world's brightest minds at one of the country's most influential Biotechs. Headquartered at an idyllic location in Cambridge, Cambridge, England

Funding Opportunity PA-18-668 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support students at institutions with NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor

The successful applicant will be involved in all aspects of laboratory research, including but not limited to human embryonic stem cell culture and...
From University of Wisconsin–Madison - Fri, 16 Feb 2018 17:15:23 GMT - View all Madison, WI jobs

Negotiable: Paramount Recruitment: Bioinformatics Project Manager Bioinformatics team, Central London, Permanent The 100,000 genomes project is a challenging and fast moving project with the aim to carry out whole genome sequencing on 100,000 participants. London, England